Genocea shares are plunging on termination of genital herpes treatment GEN-003.
Red Hat’s F2Q18 results significantly beat on revenue, margin and EPS.
A first glance at this hedge fund’s strategic Q2 moves in biotech sector.
201 injury found – What does it mean for First Solar?
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced the reintroduction of the generic equivalent to Depo-Provera®1 …
John Newman continues to expect NDA in 2018 for bremelanotide, while pipeline moves forward.
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) management hosted a conference call this morning to address Ocaliva safety …
CFO Paul Herendeen sought out to convince investors to put their money into the long game.
Ram Selvaraju slashes his target to $8 on slower Trulance ramp.
Amarin Corporation plc (ADR) (NASDAQ:AMRN) and HLS Therapeutics Inc. (“HLS”), announced today an exclusive agreement …